Skip to main content

Companion Animal Vaccines Market Value Chain and Forecast 2016-2026

Press Release   •   Jan 04, 2017 00:03 EST

Companion Animal Vaccines Market

Environment is shared by variety of domestic animals as companion, food source, transportation, leisure, research & pets inside and outside home. The variety of species are kept in households primarily dogs and cats which creates profound health effect on humans along with animals and they need to be protected. To protect the animals as well as family from diseases and maintaining their health owners have to vaccinate their pets on the regular basis. It helps in evading disease among various animals and also helps in enhancing production of livestock. For monitoring disease and diagnosis of domestic animals, diagnostic imaging technique is used such as magnetic resonance imaging (MRI) & computed tomography (CT). In U.S, 62% of households own a companion animals and with increasing preference for companion animals is witness the demand for companion animal vaccines in near future.

Companion Animal Vaccines Market: Drivers and Restraints

With increased prevalence of animal disease along with increasing incidence of zoonotic disease, animal welfare and government investment are some of the key factors that drives the market for companion animal vaccines. Increase in the cost of vaccines, ignorance and preference towards vegetarian food is proving a major challenge for companion animal vaccines market.

Request Free Report Sample@ 

Companion Animal Vaccines Market: Segmentation

The companion animal vaccines market has been classified on the basis of product, disease and technology.

Based on product type, the companion animal vaccines market is segmented into the following:

  • Canine
  • Feline

Based on disease type, the companion animal vaccines market is segmented into the following:

  • Canine Vaccines
    • Canine Rabies
    • Canine Distemper
    • Canine Parvovirus
    • Canine Hepatitis
    • Others
  • Feline Vaccines
    • Feline Rabies
    • Feline Panleukopenia
    • Feline Viral Rhinotracheitis
    • Feline Leukemia
    • Others

Based on technology type, the companion animal vaccines market is segmented into the following:

  • Live Attenuated Vaccines (LAV)
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • DNA Vaccines
  • Conjugate Vaccines

Companion Animal Vaccines Market: Overview

Research and development activities, new product development along with various collaborations and prominent strategies adopted by various vaccine manufactures to enhance and expand their market share are propelling the growth of companion animal vaccines market during the forecast period.

Companion Animal Vaccines Market: Region-wise Outlook

Depending on geographic region, companion animal vaccines marketis segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Europe accounts for largest market share of the global companion animal vaccines market followed by North America, Japan and Asia Pacific owing to high awareness among population and increase in the preference for owning companion animals. The developing nations in Latin America, Middle East and Africa hold huge potential and a promising market for companion animal vaccines market due to increase in investment opportunities and vast untapped market.

Request For TOC@ 

Companion Animal Vaccines Market: Key Players

Key players of companion animal vaccines marketare Bayer Healthcare, Merial Inc. (Sanofi), Bioniche animal Health (Canada), Boehringer Ingelheim (Germany), Zoetis (U.S), Heska Corporation, Merck Animal Health (U.S), Novartis Animal Health Inc., Virbac and others.

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.


3rd Floor,
207 Regent Street,
London - W1B 3HH
United Kingdom
T: + 44 (0) 20 7692 8790
D: +44 (0) 20 3287 4268

Comments (0)

Add comment